Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska
About Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
Abivax S.A.
3
Janssen Research & Development, LLC
3
Allergan
2
Celgene
2
Ionis Pharmaceuticals, Inc.
2
Amgen
1
Axcella Health, Inc
1
Calliditas Therapeutics Suisse SA
1
SK Life Science, Inc.
1
Tobira Therapeutics, Inc.
1
Clinical Trials at Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska
During the past decade, Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 7 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 7 clinical trials were completed. i.e. 53.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis
2017-02-14
2021-01-05
Terminated
167
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01
2017-09-29
2020-07-08
Terminated
336
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection
2018-01-03
2020-04-30
Terminated
334
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications
2018-01-21
2020-08-24
Terminated
553
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
2018-01-24
2020-10-30
Terminated
467
Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands
2018-09-13
2021-04-02
Completed
43
Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis
2019-09-23
2021-04-16
Completed
254
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska" #1 sponsor was "Pfizer" with 4 trials, followed by "Abivax S.A." with 3 trials
sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Allergan" with 2 trials sponsored and "Celgene"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska
According to Clinical.Site data, the most researched conditions in "Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska" are
"COVID-19" (3 trials), "Ulcerative Colitis" (3 trials), "Acromegaly" (2 trials), "Diabetes Mellitus" (2 trials) and "Eosinophilic Esophagitis" (2 trials). Many other conditions were trialed in "Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska" in a lesser frequency.
Clinical Trials Intervention Types at Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska
Most popular intervention types in "Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska" are "Drug" (20 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "PF-07321332" (3 trials), "Ritonavir" (3 trials), "ABX464" (2 trials) and "CC-93538" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska
The vast majority of trials in "Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska" are
21 trials for "All" genders.
Clinical Trials Status at Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska
Currently, there are NaN active trials in "Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska".
undefined are not yet recruiting,
6 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska, 1 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".